Z. An

Nature · 2009–2021

A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from Z. An's perspective

Ordered by how strongly the researchers Z. An trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. (New England Journal of Medicine)
  2. A history of cancer chemotherapy. (Cancer Research)
  3. Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index (Nature Biotechnology)
  4. Glutathione metabolism and its implications for health. (Journal of NutriLife)
  5. Immune Checkpoint Blockade in Cancer Therapy. (Journal of Clinical Oncology)
  6. FcRn: the neonatal Fc receptor comes of age
  7. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. (Advanced Drug Delivery Reviews)
  8. Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)* (Journal of Biological Chemistry)
  9. Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. (Journal of Clinical Oncology)
  10. Antibody-drug conjugates: an emerging concept in cancer therapy. (Angewandte Chemie)

Their papers